Bedtime THC: Normal Resting Measurements Did Not Exclude a Morning Tilt Response

Normal resting cardiovascular measurements the morning after THC do not establish a normal response to standing-related stress. An exploratory study found selected differences during head-up tilt, particularly among participants without regular cannabis use.

Rest and challenge were different endpoints

Adults with and without regular cannabis use underwent morning cardiovascular testing after placebo and bedtime oral THC. Measurements included heart rate, blood pressure and heart-rate variability during rest, tilt and recovery.

This was a physiological challenge study, rather than a driving assessment or a test of every cause of fainting. A resting reading and a response to a change in posture answer different questions.

The significant finding was selective

A group-by-treatment-by-time interaction was significant for diastolic blood pressure. Follow-up comparison showed lower diastolic pressure during tilt after THC than after placebo in the group without cannabis use. Other measured outcomes did not uniformly show significant interactions.

The authors also described increased dizziness and nausea during tilt in nonregular users. These observations should not be generalized into a demonstrated universal cardiovascular hazard or a precise fall-risk estimate.

Order and measurement limitations matter

The study was single-blind and oral THC administration was not randomized. Treatment order could therefore contribute to differences. The small sample and unusable ECG segments also limited the information available for some analyses.

Blood pressure was not continuously measured beat to beat. The experiment could not fully characterize moment-to-moment hemodynamic changes or establish a detailed baroreflex mechanism. Hydration remained another consideration for future studies.

What a next-morning opinion can say

The result challenges the assumption that a normal resting examination proves recovery of every physiological response. It does not provide a cannabis concentration cutoff, a universal next-morning impairment classification or proof that a particular person’s dizziness was THC-caused.

An individual assessment requires the dose, timing, medicines, hydration, symptoms and relevant clinical testing. Resting stability, orthostatic response and capacity for driving or work should remain separate conclusions.

For context, see our discussion of THC concentrations and the separate question of impairment.

Primary research

Joshua E. Gonzalez and colleagues. Bedtime tetrahydrocannabinol ingestion reduces morning orthostatic cardiovascular reactivity in adults: An exploratory study. Physiological Reports (2026). DOI: 10.14814/phy2.71076.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Other Medications Changed THC/CBD Spray Exposure in Different Directions

The effect of another medication on THC/CBD exposure depends on the drug and the pathway involved. A human interaction study found lower cannabinoid exposure with rifampicin, higher exposure with ketoconazole, and no significant pharmacokinetic change with omeprazole under the tested conditions. Three separate crossover comparisons Stott and colleagues studied 36…

Spread the love

Read Article: Other Medications Changed THC/CBD Spray Exposure in Different Directions

An Intermediate CBD Stress Response Was Not a Significant Placebo Difference

A CBD group’s average response can fall between placebo patients and healthy controls without demonstrating a significant CBD-versus-placebo benefit. A study of social stress in people at clinical high risk of psychosis illustrates this statistical distinction. Stress hormones and subjective symptoms were separate endpoints Participants at clinical high risk received…

Spread the love

Read Article: An Intermediate CBD Stress Response Was Not a Significant Placebo Difference

Two-Dimensional Cannabis GC–MS Testing Needs Correctly Timed Transfer Windows

Adding a second chromatography column can improve cannabinoid separation while introducing a new failure point: the analyte must reach the second column during the correct transfer window. A plasma assay study showed why those windows require verification. More separation brought more timing requirements Karschner and colleagues developed two-dimensional gas chromatography–mass…

Spread the love

Read Article: Two-Dimensional Cannabis GC–MS Testing Needs Correctly Timed Transfer Windows

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us